AU2010244983B2 - Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition - Google Patents

Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition Download PDF

Info

Publication number
AU2010244983B2
AU2010244983B2 AU2010244983A AU2010244983A AU2010244983B2 AU 2010244983 B2 AU2010244983 B2 AU 2010244983B2 AU 2010244983 A AU2010244983 A AU 2010244983A AU 2010244983 A AU2010244983 A AU 2010244983A AU 2010244983 B2 AU2010244983 B2 AU 2010244983B2
Authority
AU
Australia
Prior art keywords
skin
composition
light
treatment
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010244983A
Other languages
English (en)
Other versions
AU2010244983A1 (en
Inventor
William Anseline
Daryll Ian Knowles
Peter Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ALLMEDIC Pty Ltd
Original Assignee
ALLMEDIC Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009902049A external-priority patent/AU2009902049A0/en
Application filed by ALLMEDIC Pty Ltd filed Critical ALLMEDIC Pty Ltd
Priority to AU2010244983A priority Critical patent/AU2010244983B2/en
Publication of AU2010244983A1 publication Critical patent/AU2010244983A1/en
Application granted granted Critical
Publication of AU2010244983B2 publication Critical patent/AU2010244983B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2010244983A 2009-05-08 2010-05-10 Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition Ceased AU2010244983B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2010244983A AU2010244983B2 (en) 2009-05-08 2010-05-10 Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2009902049A AU2009902049A0 (en) 2009-05-08 Treatment of pain and/or inflammation
AU2009902049 2009-05-08
PCT/AU2010/000539 WO2010127411A1 (fr) 2009-05-08 2010-05-10 Traitement de la douleur et/ou de l'inflammation et traitement et prévention d'une maladie et/ou d'une affection de la peau ou de muqueuses
AU2010244983A AU2010244983B2 (en) 2009-05-08 2010-05-10 Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition

Publications (2)

Publication Number Publication Date
AU2010244983A1 AU2010244983A1 (en) 2011-11-17
AU2010244983B2 true AU2010244983B2 (en) 2015-07-16

Family

ID=43049857

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010244983A Ceased AU2010244983B2 (en) 2009-05-08 2010-05-10 Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition

Country Status (3)

Country Link
EP (1) EP2429559A4 (fr)
AU (1) AU2010244983B2 (fr)
WO (1) WO2010127411A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102846860A (zh) * 2012-09-07 2013-01-02 叶志群 一种治疗风热袭肺型荨麻疹的内服药酒
JP6495183B2 (ja) * 2013-01-30 2019-04-03 ボリス ゴリンステイン 表面の創傷を処置するための組成物および方法
EP3520818A1 (fr) * 2018-02-01 2019-08-07 AC BioScience SA Compositions pour le traitement et/ou la prévention des effets secondaires d'une thérapie photodynamique

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124320A (en) * 1989-09-12 1992-06-23 Ivy Jeffery W An external analgesic lotion containing active ingredients of camphor and menthol and method of making such lotion
CN1202364A (zh) * 1997-06-13 1998-12-23 湖南中医学院第一附属医院 缓解心绞痛油剂
WO2004010958A2 (fr) * 2002-07-31 2004-02-05 Shaklee Corporation Procede permettant de maximiser la sante du cuir chevelu et d'induire une amelioration de la qualite des cheveux d'un point de vue visuel et tactile
JP2006335680A (ja) * 2005-06-02 2006-12-14 Gero Kosha:Kk 皮膚外用剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5013726A (en) * 1989-09-12 1991-05-07 Ivy Jeffery W External analgesic lotion containing active ingredients of methyl salicylate and camphor and menthol and method of making such lotion
US5760079A (en) * 1995-05-23 1998-06-02 Dermatology Home Products Inc. Method of applying alpha hydroxy acids for treating striae distensae
DE69804130T2 (de) * 1997-11-25 2002-07-25 Yamanouchi Europ Bv Verwendung eines gemischs aus einem diol und einer alpha-hydroxysäure zur behandlung hyperkeratotischer hauterkrankungen

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5124320A (en) * 1989-09-12 1992-06-23 Ivy Jeffery W An external analgesic lotion containing active ingredients of camphor and menthol and method of making such lotion
CN1202364A (zh) * 1997-06-13 1998-12-23 湖南中医学院第一附属医院 缓解心绞痛油剂
WO2004010958A2 (fr) * 2002-07-31 2004-02-05 Shaklee Corporation Procede permettant de maximiser la sante du cuir chevelu et d'induire une amelioration de la qualite des cheveux d'un point de vue visuel et tactile
JP2006335680A (ja) * 2005-06-02 2006-12-14 Gero Kosha:Kk 皮膚外用剤

Also Published As

Publication number Publication date
AU2010244983A1 (en) 2011-11-17
EP2429559A1 (fr) 2012-03-21
WO2010127411A1 (fr) 2010-11-11
EP2429559A4 (fr) 2013-08-14

Similar Documents

Publication Publication Date Title
Champeau et al. Photodynamic therapy for skin cancer: How to enhance drug penetration?
Sakamoto et al. Photodynamic therapy for acne vulgaris: a critical review from basics to clinical practice: part II. Understanding parameters for acne treatment with photodynamic therapy
Ozog et al. Photodynamic therapy: a clinical consensus guide
Kasche et al. Photodynamic therapy induces less pain in patients treated with methyl aminolevulinate compared to aminolevulinic acid
ES2546381T3 (es) Utilización de ácido aminolevulínico y derivados del mismo
US20100298758A1 (en) Method for non-therapeutic or therapeutic photodynamic skin treatment
US20090131499A1 (en) Photodynamic therapy for skin related problems
US20100255080A1 (en) Liposomal ALA pharmaceutical and cosmeceutical compositions and methods of treatment
US9561276B2 (en) Method of treating onychomycosis
AU2010244983B2 (en) Treatment of pain and/or inflammation and treatment and prevention of a skin or mucosal disease and/or condition
Zhang et al. Conventional versus daylight photodynamic therapy for acne vulgaris: A randomized and prospective clinical study in China
Silva et al. Photodynamic therapy: dermatology and ophthalmology as main fields of current applications in clinic
Silapunt et al. Topical and light-based treatments for actinic keratoses
Peterson et al. Photodynamic therapy
Jennifer Rivard et al. Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy
ES2778031T3 (es) Método para el tratamiento del acné
RU2621845C2 (ru) Способ фотодинамической терапии неонкологических косметических дефектов кожи
Taub 5-Aminolevulinic acid: acne vulgaris
Sidoroff Topical sensitization—oncologic indications—actinic keratoses
Gold Lasers, Photodynamic Therapy, and the Treatment of Medical Dermatologic Conditions
Schleyer et al. ALA/MAL-PDT in dermatology
Hommel et al. Photodynamic Therapy (PDT)
Satoskar et al. Management of oral leukoplakia with photodynamic therapy
Lee et al. A case of Bowen's disease partially responded to photodynamic therapy
Gilbert How I Use Photodynamic Therapy with 5-Aminolevulinic Acid in My Clinical Practice

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application
NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 10 MAY 2014 TO 10 DEC 2014 IN WHICH TO PAY A CONTINUATION FEE HAS BEEN FILED .

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO PAY A CONTINUATION FEE HAS BEEN EXTENDED TO 10 DEC 2014 .

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired